Friday’s approval by the Food and Drug Administration of Pfizer and Moderna COVID-19 vaccinations for emergency use in children younger than 5 years old was a huge step for parents who have been stranded at school for two years daycare while also taking precautions to protect their children’s health.
The Centers for Disease Control and Prevention may approve preschool shots before June.
Moderna’s vaccine was also approved for school-aged children and teens and added another option to Pfizer, according to The Associated Press.
Children younger than 5 years old are the only ones in the U.S. not eligible for the COVID-19 vaccine. This leaves them particularly vulnerable to the virus in an environment with a record number of omicron variants infected children.
Moderna applied for FDA approval in late April for its 25-microgram two-dose regimen. The company stated that data from a vaccine study involving 6,700 children aged 6 and under showed similar results against omicron for adults and children.
Who will give three shots of the Pfizer-BioNTech vaccine to younger children? This is compared to the 10 micrograms pediatric dose approved for children aged 5-12. Adults and teens, however, receive 30 micrograms each shot.
In an unusual move and at the request of federal regulators, Pfizer initially requested approval in February for a two-dose regimen. However, data from a 2021 study suggested that Who likely needed three doses for strong immunity.
According to a source familiar with FDA’s thinking, “We know two doses aren’t enough.” Who informed the Washington Post at the time. Let’s review two doses. If your submission is valid, you can start children on their primary baseline a month earlier than if nothing is done until the third dose data has been received.
Pfizer withdrew its application one week later, stating it preferred to wait and ask for approval for all three doses simultaneously.